The FDA just approved a new ADHD medication that targets THREE neurotransmitters 👀 Centanafadine (Simtriyo) is the first norepinephrine, dopamine and serotonin reuptake inhibitor approved for ADHD. Here’s the pharmacology behind how it works. 💊 #ADHD #ADHDMedication #Centanafadine #Simtriyo #Pharmacist
1:10
The FDA just approved a new ADHD medication that targets THREE neurotransmitters 👀 Centanafadine (Simtriyo) is the first norepinephrine, dopamine and serotonin reuptake inhibitor approved for ADHD. Here’s the pharmacology behind how it works. 💊 #ADHD #ADHDMedication #Centanafadine #Simtriyo #Pharmacist
1.6M views3 months ago
TikTokmillennialrx
See more
Static thumbnail place holder